GHRL and pancreatic adenocarcinoma: According to the results of a pancreatic adenocarcinoma study, ghrelin promoted cell migration via the activation of GHSR/PI3K/Akt signaling pathway, and the phenotype was inhibited by the addition of ghrelin receptor antagonist [29].